Clinical Trial Update: Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion and results posting of a Phase 1/2 study evaluating a conditioning regimen of clofarabine, melphalan, and alemtuzumab in pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Clolar (Clofarabine)
• Melphalan (Melphalan)

Snippet

Sponsor: University of Chicago | Conditions: Advanced Hematologic Malignancies, Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-02-27